{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:08:59Z","timestamp":1769551739590,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amsu.2021.103023","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T08:24:36Z","timestamp":1635927876000},"page":"103023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hajdu Cheney syndrome; A novel NOTCH2 mutation in a Syrian child, and treatment with zolidronic acid: A case report and a literature review of treatments"],"prefix":"10.1097","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-1525","authenticated-orcid":false,"given":"Afaf","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-4110","authenticated-orcid":false,"given":"Diana","family":"Alasmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.amsu.2021.103023_bib1","first-page":"595","article-title":"ACRO-OSTEOLYSIS","volume":"94","author":"Cheney","year":"1965","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"issue":"4","key":"10.1016\/j.amsu.2021.103023_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11914-016-0311-6","article-title":"Hajdu-cheney syndrome, a disease associated with NOTCH2 mutations","volume":"14","author":"Canalis","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.amsu.2021.103023_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.metabol.2017.08.002","article-title":"Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders","volume":"80","author":"Canalis","year":"2018","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.amsu.2021.103023_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2016.08.025","article-title":"Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab","volume":"92","author":"Adami","year":"2016","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.amsu.2021.103023_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng.778","article-title":"Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis","volume":"43","author":"Isidor","year":"2011","journal-title":"Nat. Genet."},{"issue":"17","key":"10.1016\/j.amsu.2021.103023_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17176174","article-title":"Hajdu-Cheney Syndrome: a systematic review of the literature","volume":"17","author":"Cort\u00e9s-Mart\u00edn","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"1","key":"10.1016\/j.amsu.2021.103023_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2012.10.027","article-title":"Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome","volume":"52","author":"Stathopoulos","year":"2013","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.amsu.2021.103023_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4","article-title":"Hajdu--Cheney syndrome: evolution of phenotype and clinical problems","volume":"100","author":"Brennan","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.amsu.2021.103023_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1096-8628(19980806)78:5<474::AID-AJMG14>3.0.CO;2-C","article-title":"Further evidence that the Hajdu-Cheney syndrome and the \"serpentine fibula-polycystic kidney syndrome\" are a single entity","volume":"78","author":"Ramos","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.amsu.2021.103023_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00247-008-0992-9","article-title":"Hajdu-Cheney syndrome associated with serpentine fibulae and polycystic kidney disease","volume":"39","author":"Currarino","year":"2009","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.amsu.2021.103023_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-014-0200-y","article-title":"Hajdu-Cheney syndrome: a review","volume":"9","author":"Canalis","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.amsu.2021.103023_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos. Int. : J. Establ Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"10","key":"10.1016\/j.amsu.2021.103023_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.amsu.2021.103023_bib14","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-13-0115","article-title":"Notch signaling in skeletal health and disease","volume":"168","author":"Zanotti","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.amsu.2021.103023_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm1712","article-title":"Dimorphic effects of Notch signaling in bone homeostasis","volume":"14","author":"Engin","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.amsu.2021.103023_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm1716","article-title":"Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation","volume":"14","author":"Hilton","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.amsu.2021.103023_bib17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/MCB.01285-09","article-title":"Notch and the skeleton","volume":"30","author":"Zanotti","year":"2010","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.amsu.2021.103023_bib18","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/en.2008-0140","article-title":"Notch inhibits osteoblast differentiation and causes osteopenia","volume":"149","author":"Zanotti","year":"2008","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.amsu.2021.103023_bib19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00198-013-2298-5","article-title":"Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome","volume":"24","author":"Zhao","year":"2013","journal-title":"Osteoporos. Int. : J. Establ Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"10","key":"10.1016\/j.amsu.2021.103023_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/bjs.1800601016","article-title":"The aetiology of hypertension after renal transplantation in man","volume":"60","author":"Sampson DK","year":"1973","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.amsu.2021.103023_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/humu.21546","article-title":"Mutations in NOTCH2 in families with Hajdu-Cheney syndrome","volume":"32","author":"Majewski","year":"2011","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.amsu.2021.103023_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MCD.0000000000000034","article-title":"Hajdu-Cheney syndrome: phenotypical progression with de-novo NOTCH2 mutation","volume":"23","author":"Descartes","year":"2014","journal-title":"Clin. Dysmorphol."},{"issue":"2","key":"10.1016\/j.amsu.2021.103023_bib23","doi-asserted-by":"crossref","first-page":"103650","DOI":"10.1016\/j.ejmg.2019.04.007","article-title":"Phenotypic presentations of Hajdu-Cheney syndrome according to age - 5 distinct clinical presentations","volume":"63","author":"Graversen","year":"2020","journal-title":"Eur. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.amsu.2021.103023_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jbspin.2013.02.008","article-title":"A mutation in NOTCH2 gene in a Chinese patient with Hajdu-Cheney syndrome","volume":"80","author":"Gu","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.amsu.2021.103023_bib25","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/art.1780290815","article-title":"Idiopathic familial acroosteolysis: histomorphometric study of bone and literature review of the Hajdu-Cheney syndrome","volume":"29","author":"Udell","year":"1986","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.amsu.2021.103023_bib26","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1359\/jbmr.1999.14.12.2036","article-title":"Severe osteoporosis in familial Hajdu-Cheney syndrome: progression of acro-osteolysis and osteoporosis during long-term follow-up","volume":"14","author":"Leidig-Bruckner","year":"1999","journal-title":"J. Bone Miner. Res. : Off. J. Am. Soc. Bone Min. Res."},{"issue":"3","key":"10.1016\/j.amsu.2021.103023_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2040622310374783","article-title":"Bisphosphonates for the treatment of osteoporosis: insights for clinicians","volume":"1","author":"Lewiecki","year":"2010","journal-title":"Therapeut. Adv. Chronic Dis."},{"issue":"9","key":"10.1016\/j.amsu.2021.103023_bib28","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.amsu.2021.103023_bib29","first-page":"235","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"20","key":"10.1016\/j.amsu.2021.103023_bib30","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.amsu.2021.103023_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/0002512-200825110-00007","article-title":"Zoledronic acid: a review of its use in the treatment of osteoporosis","volume":"25","author":"Deeks","year":"2008","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.amsu.2021.103023_bib32","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/jc.2017-01102","article-title":"Bone structural characteristics and response to bisphosphonate treatment in children with hajdu-cheney syndrome","volume":"102","author":"Sakka","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.amsu.2021.103023_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12020-020-02446-7","article-title":"A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment","volume":"71","author":"Efstathiadou","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.amsu.2021.103023_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-018-0795-5","article-title":"Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review","volume":"13","author":"Pittaway","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.amsu.2021.103023_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg."}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080121009730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080121009730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:09:34Z","timestamp":1677082174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080121009730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S2049080121009730"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2021.103023","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hajdu Cheney syndrome; A novel NOTCH2 mutation in a Syrian child, and treatment with zolidronic acid: A case report and a literature review of treatments","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2021.103023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103023"}}